OraSure to Present at the J.P Morgan Healthcare Conference
OraSure Technologies (NASDAQ: OSUR), a leading provider of point-of-need and home diagnostic tests and sample management solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver their presentation on Thursday, January 16, 2025, at 9:00 a.m. PT.
Interested parties can access both a live webcast and replay of the presentation through the 'Events and Presentations' section of OraSure's investor relations website. This significant healthcare industry event provides OraSure an opportunity to showcase its developments and strategies to investors and healthcare professionals.
OraSure Technologies (NASDAQ: OSUR), un fornitore leader di test diagnostici a punto di bisogno e soluzioni di gestione dei campioni, ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. Il team di gestione dell'azienda presenterà il proprio intervento giovedì 16 gennaio 2025, alle 9:00 PT.
Le parti interessate possono accedere sia a una diretta streaming che a una registrazione della presentazione attraverso la sezione 'Eventi e Presentazioni' del sito web delle relazioni con gli investitori di OraSure. Questo importante evento del settore sanitario offre a OraSure l'opportunità di mettere in mostra i propri sviluppi e strategie a investitori e professionisti della salute.
OraSure Technologies (NASDAQ: OSUR), un proveedor líder de pruebas diagnósticas en el lugar de necesidad y soluciones de gestión de muestras, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. El equipo de gestión de la compañía presentará su intervención el jueves 16 de enero de 2025, a las 9:00 a.m. PT.
Las partes interesadas pueden acceder tanto a una transmisión en vivo como a una repetición de la presentación a través de la sección 'Eventos y Presentaciones' del sitio web de relaciones con inversores de OraSure. Este importante evento de la industria de la salud brinda a OraSure la oportunidad de mostrar sus desarrollos y estrategias a inversores y profesionales de la salud.
오라셰어 테크놀로지스 (NASDAQ: OSUR)는 필요에 따라 검사 및 샘플 관리 솔루션의 선도적인 제공업체로, 제43회 J.P. 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2025년 1월 16일 목요일 오전 9시 PT에 발표를 진행할 예정입니다.
관심 있는 분들은 오라셰어의 투자자 관계 웹사이트의 '이벤트 및 발표' 섹션을 통해 생중계와 발표 재생 모두에 접근할 수 있습니다. 이 중요한 의료 산업 이벤트는 오라셰어가 투자자 및 의료 전문가에게 자사의 개발 및 전략을 선보일 수 있는 기회를 제공합니다.
OraSure Technologies (NASDAQ: OSUR), un fournisseur de premier plan de tests diagnostiques à point de besoin et de solutions de gestion d'échantillons, a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de l'entreprise présentera son intervention le jeudi 16 janvier 2025, à 9h00 PT.
Les parties intéressées peuvent accéder à la fois à un webinaire en direct et à un replay de la présentation via la section 'Événements et Présentations' du site web des relations avec les investisseurs d'OraSure. Cet événement majeur de l'industrie de la santé offre à OraSure l'opportunité de présenter ses développements et ses stratégies aux investisseurs et aux professionnels de la santé.
OraSure Technologies (NASDAQ: OSUR), ein führender Anbieter von Point-of-Need- und Heimdiagnosetests sowie Probenmanagementlösungen, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference bekannt gegeben. Das Managementteam des Unternehmens wird seine Präsentation am Donnerstag, den 16. Januar 2025, um 9:00 Uhr PT halten.
Interessierte können sowohl eine Live-Übertragung als auch eine Wiederholung der Präsentation über den Bereich 'Veranstaltungen und Präsentationen' auf der Investor-Relations-Website von OraSure abrufen. Diese bedeutende Veranstaltung der Gesundheitsbranche bietet OraSure die Gelegenheit, seine Entwicklungen und Strategien Investoren und Gesundheitsfachleuten vorzustellen.
- None.
- None.
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate in the 43rd Annual J.P. Morgan Healthcare Conference. OraSure’s presentation is scheduled for Thursday, January 16, 2025 at 9:00 a.m. PT.
A live webcast and replay of the presentation will be available in the “Events and Presentations” section of OraSure’s investor relations website at https://orasure.gcs-web.com/events-and-presentations.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com
| Investor Contact: | Media Contact: |
| Jason Plagman | Amy Koch |
| VP, Investor Relations | Director, Corporate Communications |
| investorinfo@orasure.com | media@orasure.com |
FAQ
When is OraSure Technologies (OSUR) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch OraSure's (OSUR) J.P. Morgan Healthcare Conference presentation?
Which members of OraSure (OSUR) will be presenting at the 2025 J.P. Morgan Healthcare Conference?
What is the significance of OraSure's (OSUR) participation in the J.P. Morgan Healthcare Conference?
